A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)

Clinical trial NCT00648167 · COMPLETED

Trial details

NCT number: NCT00648167
Sponsor: Keryx Biopharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperphosphatemia End-stage Renal Disease

Start date: 2008-03-01
Primary completion: 2009-01-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.